SOD2 and breast cancer: We have previously shown that MnSOD-K68-Ac is enriched in a subgroup of luminal B breast malignancies 30, which commonly recur with endocrine therapy, and is a mitochondrial based signaling network for the development of tamoxifen resistance (TamR), as determined using breast cancer tissue culture cells.